Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections: a Prospective Randomized Superiority Trial

NCT06695585 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.

NCT NCT06695585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06695585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections: a Prospective Randomized Superiority Trial
Lead sponsor
University of Louisville
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 1, 2024
Completion date
December 1, 2025
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurogenic bladder, overactive bladder, overactive bladder syndrome, urge incontinence, urinary frequency, urinary urgency